Deal facts
- Buyer
- Boots UK Limited
- Target
- Concepta Diagnostics Limited
- Deal value
- Not disclosed
- Announced
- 10 November 2025
- Status
- Completed
- Sector
- Healthcare
- Country
- Not stated
- Consideration
- cash
Sources
The deal structure involves an asset sale of Concepta Diagnostics Limited. This transaction was announced on 10 November 2025 and was reported as completed on the same day. The consideration for this asset sale was structured using cash.
The details provided confirm the completion of the asset sale concerning Concepta Diagnostics Limited. No information regarding the buyer's identity or the specific value of the transaction was reported in the available facts. The transaction is reported as completed.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Completion of Disposal and Board Changes
Disclaimer* MyHealthChecked PLC ( " MyHealthChecked " or the "Company " ) Completion of Disposal and Board Changes MyHealthChecked PLC (AIM: MHC) announces, further to the notification of 4 November 2025, that the disposal of Concepta Diagnostics Limited ("Disposal") completed earlier today. Following completion of the Disposal, the Board Changes detailed in the notif
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Larry King
Silo Pharma, Inc. has completed the acquisition of assets from Larry King. The transaction, which was announced on 14 October 2026, was finalized on 13 October 2026. Bot…
- Buyer
- Silo Pharma, Inc.
- Target
- Larry King
- Deal value
- Not disclosed
- Deal type
- asset sale
Silo Pharma, Inc. to acquire Norsight Consulting Inc.
Silo Pharma, Inc. has agreed to acquire assets from Norsight Consulting Inc. in a transaction announced on 2 October 2026. Both companies are based in the United States…
- Buyer
- Silo Pharma, Inc.
- Target
- Norsight Consulting Inc.
- Deal value
- Not disclosed
- Deal type
- asset sale
JOINT Corp to acquire The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
JOINT Corp has agreed to acquire a portfolio of five Texas-based entities from The Joint franchise network. The transaction, announced and completed on 1 October 2026, i…
- Buyer
- JOINT Corp
- Target
- The Joint Franchises San Antonio, LLC, The Joint Franchises DFW, LLC, The Joint Franchises Houston, LLC, The Joint Franchises Austin, LLC, and The Joint Franchises Texas, Ltd.
- Deal value
- USD 8,000,000
- Deal type
- asset sale
Element Biosystems, LLC to acquire Standard BioTools Inc.
Element Biosystems, LLC has agreed to acquire Standard BioTools Inc. in a cash asset sale. The transaction was announced on 30 September 2026 and is valued at five milli…
- Buyer
- Element Biosystems, LLC
- Target
- Standard BioTools Inc.
- Deal value
- USD 5,500,000
- Deal type
- asset sale
Buyer history
Boots UK Limited
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive